Justin Claeys | executive |
Robert Bradway | executive |
Murdo Gordon | executive |
Vikram Karnani | executive |
James Bradner | executive |
Peter Griffith | executive |
Michael Yee | analyst |
Salveen Richter | analyst |
Jay Olson | analyst |
Christopher Schott | analyst |
Evan Seigerman | analyst |
Umer Raffat | analyst |
David Reese | executive |
Colin Bristow | analyst |
Brendan Smith | analyst |
Mohit Bansal | analyst |
Geoffrey Meacham | analyst |
David Risinger | analyst |
Timothy Anderson | analyst |
Nicole Germino | analyst |
James Shin | analyst |
Carter L. Gould | analyst |
My name is Julianne, and I will be your conference facilitator today for Amgen's Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] I would now like to introduce Justin Claeys, Vice President of Investor Relations. Please, you may now begin.
Thank you Julianne. Good afternoon, and welcome to our fourth quarter 2023 earnings call.